Sigachi Industries
- P/E
- 41.94
Key Fundamentals
MicrocapPharmaceuticals & BiotechnologyHealthcarePrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 6.14%
- Debt to Equity
- 0.31
- EPS (TTM)
- ₹0.67
- Book Value
- ₹14.12
- Market Cap
- —
- P/E (TTM)
- 41.94
- P/B
- 1.99
- ROE
- 5.78%
- Dividend Yield
- 0.38%
- EBITDA
- ₹62.00 Cr
- 52W High
- ₹40.80
- 52W Low
- ₹16.65
- Day Range
- ₹26.25 – ₹28.59
- Volume
- 30,04,764
Peer Comparison
Healthcare › Pharmaceuticals
| ₹1,773.40 | 38.81 | ₹4,29,049 Cr | 4.77 | 0.90% | 16.00% | 20.50% | ₹61,631 Cr | ₹10,987 Cr | |
| ₹10,037.50 | 91.10 | ₹2,65,269 Cr | 15.90 | 0.30% | 16.50% | 22.00% | ₹11,230 Cr | ₹2,925 Cr | |
| ₹4,738.50 | 78.61 | ₹1,77,061 Cr | 9.81 | 0.82% | 27.40% | 15.20% | ₹17,400 Cr | ₹2,099 Cr | |
| ₹1,188.10 | 26.44 | ₹1,25,446 Cr | 4.37 | 0.08% | 21.20% | 21.10% | ₹28,592 Cr | ₹4,593 Cr | |
| ₹2,323.80 | 114.81 | ₹1,25,228 Cr | 20.72 | 0.04% | 18.30% | 17.80% | ₹7,270 Cr | ₹1,090 Cr | |
| ₹1,374.00 | 35.59 | ₹1,14,543 Cr | 2.96 | 0.58% | 11.20% | 13.00% | ₹33,228 Cr | ₹3,184 Cr | |
| ₹1,402.00 | 33.59 | ₹1,12,454 Cr | 3.20 | 0.93% | 11.60% | 15.50% | ₹28,324 Cr | ₹3,356 Cr | |
| Sigachi Industries (this company) | ₹28.10 | 41.94 | ₹1,021 Cr | 1.99 | 0.38% | 5.78% | 6.14% | ₹471 Cr | ₹26 Cr |
| Median 8 companies | ₹1,587.70 | 40.38 | ₹1,25,337 Cr | 4.57 | 0.48% | 16.25% | 16.65% | ₹22,862 Cr | ₹3,055 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 36
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 49
- Average
- Cheap vs sector & own history 24% weight
- Growth
- 3
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 35
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 60
- Good
- Trend strength, vol-adjusted 12% weight
- Ownership
- 36
- Poor
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
4- Tax rate seems low
- Company has a low return on equity of 11.2% over last 3 years.
- Company has high debtors of 171 days.
- Promoter holding has decreased over last 3 years: -11.8%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 3 | 5 | 11 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bullish | 1 | 0 | 9 |
Oscillators
Neutral
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 53.06
- Neutral
- MACD (12,26,9)
- −0.78
- Bullish
- SMA (50)
- 29.94
- Bearish
- SMA (200)
- 24.33
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | +19.89% |
|---|---|
| 3Y | +16.54% |
| 1Y | −2.05% |
| TTM | −9.58% |
Net profit
| 5Y | Turned to loss |
|---|---|
| 3Y | Turned to loss |
| 1Y | Turned to loss |
| TTM | Turned to profit |
Operating cash flow
| 5Y | Turned negative |
|---|---|
| 3Y | Turned negative |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | −8.91 pp |
|---|---|
| 3Y | −8.24 pp |
| 1Y | −9.19 pp |
| TTM | −9.99 pp |
Revenue by year
| Mar 2018 | ₹101 Cr |
|---|---|
| Mar 2019 | ₹129 Cr |
| Mar 2020 | ₹139 Cr |
| Mar 2021 | ₹193 Cr |
| Mar 2022 | ₹250 Cr |
| Mar 2023 | ₹302 Cr |
| Mar 2024 | ₹399 Cr |
| Mar 2025 | ₹488 Cr |
| Mar 2026 | ₹478 Cr |
Net profit by year
| Mar 2018 | ₹7.00 Cr |
|---|---|
| Mar 2019 | ₹19.00 Cr |
| Mar 2020 | ₹20.00 Cr |
| Mar 2021 | ₹30.00 Cr |
| Mar 2022 | ₹40.00 Cr |
| Mar 2023 | ₹44.00 Cr |
| Mar 2024 | ₹57.00 Cr |
| Mar 2025 | ₹70.00 Cr |
| Mar 2026 | −₹83.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 84.7 | 99.18 | 111 | 104 | 95.71 | 125 | 139 | 128 | 128 | 110 | 117 | 122 | 121 | 130 |
| Expenses | 68.39 | 77.76 | 88.36 | 87.8 | 74.69 | 108 | 106 | 99.65 | 104 | 103 | 111 | 105 | 105 | 111 |
| Operating Profit | 16.31 | 21.42 | 22.59 | 16.33 | 21.02 | 17.23 | 33.17 | 28.55 | 24.11 | 7.52 | 5.72 | 16.41 | 16.51 | — |
| OPM % | 19.26% | 21.6% | 20.36% | 15.68% | 21.96% | 13.8% | 23.79% | 22.27% | 18.8% | 6.81% | 4.88% | 13.46% | 13.61% | — |
| Other Income | 1.63 | 1.11 | 1.71 | 7.24 | 1.68 | 14.64 | 2.02 | 2.19 | −117 | 7.15 | −0.26 | 0.21 | 1 | 0.22 |
| Interest | 1.27 | 1.79 | 1.84 | 2.87 | 3.16 | 2.1 | 3.82 | 3.33 | 3.31 | 3.13 | 3.13 | 4.33 | 3.01 | 3.85 |
| Depreciation | 1.96 | 2.52 | 2.82 | 3.49 | 3.15 | 3.22 | 4.67 | 4.74 | 4.72 | 4.11 | 4.18 | 4.57 | 4.41 | 4.42 |
| PBT | 14.71 | 18.21 | 19.64 | 17.21 | 16.39 | 26.55 | 26.7 | 22.67 | −101 | 7.44 | −1.85 | 7.71 | 10.09 | — |
| Tax % | 26.04% | 17.01% | 18.02% | 11.85% | 22.21% | 20.83% | 23.22% | 28.67% | −0.02% | −41.59% | −98.92% | 0.78% | 19.33% | — |
| Net Profit | 10.88 | 15.12 | 16.1 | 15.17 | 12.76 | 21.02 | 20.51 | 16.18 | −101 | 10.53 | −0.02 | 7.65 | 8.14 | 8.78 |
| EPS (₹) | 0.35 | 0.49 | 0.5 | 0.46 | 0.4 | 0.65 | 0.64 | 0.35 | −2.63 | 0.28 | 0.01 | 0.2 | 0.18 | — |
Sep 2026: from the results filed on 31 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 101 | 129 | 139 | 193 | 250 | 302 | 399 | 488 | 478 | 471 |
| Expenses | 89 | 103 | 114 | 154 | 197 | 243 | 322 | 388 | 424 | 425 |
| Operating Profit | 12 | 26 | 25 | 39 | 53 | 59 | 77 | 100 | 54 | 46 |
| OPM % | 12% | 20% | 18% | 20% | 21% | 19% | 19% | 20% | 11% | 10% |
| Other Income | 3 | 4 | 5 | 3 | 3 | 7 | 12 | 21 | −110 | 8 |
| Interest | 4 | 3 | 2 | 1 | 1 | 4 | 8 | 12 | 14 | 14 |
| Depreciation | 1 | 2 | 2 | 2 | 3 | 7 | 11 | 16 | 18 | 17 |
| PBT | 10 | 25 | 25 | 38 | 52 | 54 | 70 | 92 | −88 | 23 |
| Tax % | 28% | 23% | 20% | 21% | 22% | 20% | 18% | 24% | −6% | — |
| Net Profit | 7 | 19 | 20 | 30 | 40 | 44 | 57 | 70 | −83 | 26 |
| EPS (₹) | 0.3 | 0.83 | 0.88 | 1.31 | 1.3 | 0 | 1.74 | 1.82 | −2.14 | 0.67 |
| Div. Payout % | 4% | 2% | 4% | 0% | 8% | — | 6% | 5% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | — |
Balance Sheet
₹ Cr| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 8 | 8 | 31 | 31 | 33 | 38 | 38 |
| Reserves | 23 | 42 | 57 | 87 | 197 | 238 | 397 | 563 | 484 |
| Borrowings | 30 | 25 | 30 | 21 | 35 | 68 | 151 | 142 | 162 |
| Other Liabilities | 16 | 21 | 14 | 18 | 24 | 37 | 113 | 103 | 157 |
| Total Liabilities | 72 | 91 | 109 | 133 | 287 | 374 | 694 | 846 | 841 |
| Fixed Assets | 26 | 29 | 32 | 38 | 53 | 122 | 254 | 370 | 325 |
| CWIP | 1 | 2 | 3 | 4 | 10 | 35 | 97 | 9 | 31 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 46 | 61 | 74 | 92 | 224 | 216 | 342 | 467 | 485 |
| Total Assets | 72 | 91 | 109 | 133 | 287 | 374 | 694 | 846 | 841 |
Cash Flow
₹ Cr| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating | 8 | 14 | 12 | 30 | 6 | 29 | 13 | 27 | −43 |
| Investing | −4 | −6 | −7 | −11 | −63 | −92 | −161 | −93 | −5 |
| Financing | −5 | −9 | 3 | −11 | 108 | 26 | 172 | 81 | 2 |
| Net Cash Flow | −1 | 0 | 8 | 7 | 51 | −37 | 24 | 15 | −46 |
| Free Cash Flow | 3 | 9 | 6 | 20 | −18 | −72 | −72 | −16 | −37 |
| CFO/EBITDA | 88 | 75 | 69 | 94 | 33 | 71 | 29 | 41 | −61 |
Ratios
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 77 | 70 | 72 | 68 | 88 | 97 | 137 | 137 | 171 |
| Inventory Days | 99 | 123 | 141 | 77 | 94 | 123 | 132 | 155 | 108 |
| Days Payable | 52 | 48 | 37 | 29 | 33 | 55 | 90 | 59 | 87 |
| Cash Conversion Cycle | 124 | 145 | 177 | 116 | 149 | 165 | 180 | 234 | 193 |
| Working Capital Days | 7 | 43 | 59 | 70 | 86 | 85 | 63 | 103 | 71 |
| ROCE % | — | 44% | 34% | 38% | 28% | 20% | 17% | 16% | 6% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sigachi Industries insights
72 extracted metrics across FY18–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · Jun 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026PPT
- Q3 FY26 concall · Feb 2026Transcript PPT Recording
- Q2 FY26 concall · Oct 2025Transcript PPT Recording
- 30 May 2026
- 24 Oct 2025
- 24 Feb 2026
- 14 Jan 2026
- 24 Dec 2025
- 9 Jul 2025
- 10 Jan 2025
- Outcome 31 Oct 2026
- General announcements 31 Oct 2026
Frequently Asked Questions about Sigachi Industries
What does Sigachi Industries Ltd do?
Where is Sigachi Industries Ltd (SIGACHI) listed?
Which sector does Sigachi Industries Ltd belong to?
What is the PE ratio of Sigachi Industries Ltd?
What is the 52-week high and low of Sigachi Industries Ltd?
Does Sigachi Industries Ltd pay dividends?
What is the Return on Equity (ROE) of Sigachi Industries Ltd?
Company Information
Incorporated in 1989, Sigachi Industries Ltd is a manufacturing and selling of MCC.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SIGACHI.md for Sigachi Industries Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.